We are live on ! Find out more
CPIG

Chicago Partners Investment Group Portfolio holdings

AUM $5B
1-Year Est. Return 26.84%
This Fund
S&P 500
This Quarter Est. Return
-2.26%
1 Year Est. Return
+26.84%
3 Year Est. Return
+75.76%
5 Year Est. Return
+80.52%
10 Year Est. Return
+204.97%
AUM
$1.85B
AUM Growth
-$68.8M
Cap. Flow
+$62.1M
Cap. Flow %
3.35%
Top 10 Hldgs %
24.59%
Holding
713
New
30
Increased
366
Reduced
201
Closed
56

Sector Composition

Rank Sector Weight
1 Energy 9.83%
2 Financials 8.28%
3 Technology 7.32%
4 Healthcare 2.47%
5 Consumer Discretionary 1.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVN
626
Eaton Vance Municipal Income Trust
EVN
$431M
$163K 0.01%
18,784
+8,550
+84% +$82.6K
F icon
627
Ford
F
$56.3B
$162K 0.01%
14,107
-2,351
-14% -$30.5K
UEC icon
628
Uranium Energy
UEC
$5.69B
$162K 0.01%
28,801
+9,844
+52% +$40.1K
SLCA
629
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$158K 0.01%
12,127
CSQ icon
630
Calamos Strategic Total Return Fund
CSQ
$3.35B
$141K 0.01%
10,668
+121
+1% +$1.78K
LPRO
631
DELISTED
Open Lending Corp
LPRO
$127K 0.01%
20,000
AAL icon
632
American Airlines Group
AAL
$10.2B
$119K 0.01%
10,547
-147
-1% -$2.28K
SCYX icon
633
SCYNEXIS
SCYX
$47.4M
$91.7K ﹤0.01%
6,665
+1,561
+31% +$37.3K
MFM
634
Aberdeen Municipal Income Fund
MFM
$222M
$88.9K ﹤0.01%
20,021
+146
+0.7% +$733
ETNB
635
DELISTED
89bio
ETNB
$71.4K ﹤0.01%
10,715
+466
+5% +$7.82K
CTSO icon
636
Cytosorbents Corp
CTSO
$22.7M
$67.4K ﹤0.01%
36,358
+16,598
+84% +$47.6K
IOVA icon
637
Iovance Biotherapeutics
IOVA
$2.89B
$61.7K ﹤0.01%
17,871
+5,000
+39% +$32.6K
WVE icon
638
Wave Life Sciences
WVE
$1.14B
$59.9K ﹤0.01%
11,136
-7,663
-41% -$35K
CVAC
639
DELISTED
CureVac
CVAC
$59.4K ﹤0.01%
+10,855
New +$95.9K
GLO
640
Clough Global Opportunities Fund
GLO
$258M
$54.3K ﹤0.01%
12,861
-28,124
-69% -$136K
DRTSW icon
641
Alpha Tau Medical Warrant
DRTSW
$83.1M
$52.9K ﹤0.01%
203,324
GERN icon
642
Geron
GERN
$1B
$52.9K ﹤0.01%
29,866
+8,557
+40% +$23.2K
WTI icon
643
W&T Offshore
WTI
$581M
$50.6K ﹤0.01%
12,462
-2,974
-19% -$12.3K
ABOS icon
644
Acumen Pharmaceuticals
ABOS
$178M
$44.9K ﹤0.01%
+13,579
New +$83.9K
VOR icon
645
Vor Biopharma
VOR
$1.27B
$37.4K ﹤0.01%
900
-353
-28% -$19.1K
CLYM
646
Climb Bio
CLYM
$782M
$32.8K ﹤0.01%
12,806
-3,764
-23% -$10.3K
ESPR
647
DELISTED
Esperion Therapeutics
ESPR
$23.5K ﹤0.01%
+29,499
New +$42.7K
CBIO
648
Crescent Biopharma
CBIO
$631M
$23.4K ﹤0.01%
200
LUMN icon
649
Lumen
LUMN
$6.75B
$21K ﹤0.01%
16,169
+815
+5% +$1.38K
BNED icon
650
Barnes & Noble Education
BNED
$437M
$18.1K ﹤0.01%
187

Similar funds

Chicago Partners Investment Group's Q3 2023 Portfolio in Review

As of Q3 2023, Chicago Partners Investment Group held 713 positions worth $1.85B, down 3.6% from $1.92B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Chicago Partners Investment Group deployed $62.1M of net new capital in Q3 2023, opening 30 new positions and adding to 366 existing holdings. Its largest new stake was Dimensional Ultrashort Fixed Income ETF: 142,825 shares worth $7.17M.

By sector, the portfolio is most concentrated in Energy at 9.8% of assets, up from 9.3% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Invesco S&P 500 Pure Growth ETF, an estimated $8.52M trimmed.

  • Chicago Partners Investment Group's largest Q3 2023 buy was Dimensional Ultrashort Fixed Income ETF: 142,825 shares worth $7.17M.
  • Chicago Partners Investment Group added most to Oneok in Q3 2023, an estimated $11.5M increase.
  • Chicago Partners Investment Group's biggest Q3 2023 reduction was Invesco S&P 500 Pure Growth ETF, cutting an estimated $8.52M.
  • Chicago Partners Investment Group fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $17.8M.
  • Chicago Partners Investment Group's ten largest holdings make up 25% of its $1.85B portfolio in Q3 2023.
  • Chicago Partners Investment Group opened 30 new positions and closed 56 in Q3 2023.
  • Chicago Partners Investment Group's portfolio value fell 3.6% quarter-over-quarter to $1.85B.

Based on Chicago Partners Investment Group's 13F filing for Q3 2023, filed 26 Oct 2023.